Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Radio Frequency ID Technology Cannot Substitute For Bar Coding, FDA Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Exemptions from bar coding requirements will not be granted for products with a low frequency of medication errors or small containers, FDA says in a draft guidance clarifying its bar coding final rule. Labelers – not distributors – will be responsible for bar code rule compliance.

You may also be interested in...



Dispensing-Level Electronic Authentication Needed To Secure Supply Chain – PhRMA

Pharmaceutical Research & Manufacturers of America recommends adoption of dispensing level electronic authentication to "secure" supply chain until radio frequency identification is ready. FDA's projection that RFID will be ready by 2007 may be "overly optimistic," trade group says.

FDA Anticounterfeiting Technology Guide Aims To Speed Industry Adoption

Agency will exercise enforcement discretion on labeling and GMP regulations that are triggered by radio frequency identification technology. FDA is working with EPC Global to establish standards of electronic pedigree.

FDA Bar Coding Final Rule Sets Two-Year Implementation Timeline For Existing Products

New products approved after April 26 would have to include bar codes on packages within 60 days. The proposed rule would have created a blanket three-year implementation period.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS062503

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel